Frontotemporal degeneration (FTD), a disease process that results in progressive damage to the temporal and/or frontal lobes of the brain, has been formally included in national research priorities to cure Alzheimer’s disease and other dementias by 2025, the Association of Frontotemporal Degeneration (AFTD) announced today. The update to the NAPA plan also coincided with AFTD’s release of a comprehensive research white paper, FTD Research and Drug Development Landscape Analysis.  For the full press release, click aqui.